Economic value of exome sequencing for suspected monogenic disorders
- PMID: 32601385
- DOI: 10.1038/s41436-020-0888-0
Economic value of exome sequencing for suspected monogenic disorders
Comment in
-
Response to Ferket et al.Genet Med. 2020 Nov;22(11):1910. doi: 10.1038/s41436-020-0889-z. Epub 2020 Jul 1. Genet Med. 2020. PMID: 32606441 No abstract available.
Comment on
-
Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes.Genet Med. 2019 Nov;21(11):2586-2593. doi: 10.1038/s41436-019-0534-x. Epub 2019 May 21. Genet Med. 2019. PMID: 31110331
References
-
- Schofield D, Rynehart L, Shresthra R, et al. Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes. Genet Med. 2019;21:2586–2593. - PubMed
-
- Stark Z, Schofield D, Alam K, et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet Med. 2017;19:867–874. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
